Who owns PHARMING GROUP NV SPON?
- Ticker: PHAR
- CUSIP Number: 71716e105
Tip: Access positions for across all investors
Analyze quarterly positions in Pharming Group Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Pharming Group Nv stock
Who bought or sold PHARMING GROUP NV SPON this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management | 45k | $745k | -11% | Mar 2026 |
|
| Morgan Stanley | 12k | $191k | 49% | Mar 2026 |
|
| SmartHarvest Portfolios | 11k | $180k | 100% | Mar 2026 |
|
| Citadel Advisors | 10k | $170k | -42% | Mar 2026 |
|
| Knoll Capital Management | 4.1k | $68k | 100% | Mar 2026 |
|
| Goss Wealth Management | 2.2k | $36k | -93% | Mar 2026 |
|
| Nalls Sherbakoff Group | 870.00 | $15k | 0% | Dec 2025 |
|
| EverSource Wealth Advisors | 557.00 | $9.3k | -38% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 400.00 | $6.7k | -50% | Mar 2026 |
|
| Stone House Investment Management | 79.00 | $1.3k | 100% | Mar 2026 |
|
| Cornerstone Financial Management | 32.00 | $532.000000 | 100% | Mar 2026 |
|
Who sold out of Pharming Group Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2025 | 20k | $360k |